NV

Nanasaheb Vishwanath Nagare

Active Director Director DIN 08332239
DIN 08332239 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Nanasaheb Vishwanath Nagare

Data last updated:

Nanasaheb Vishwanath Nagare is a Director at Arvigen Healthcare Private Limited (since 2019). The company operates in Pharma.

DIN 08332239
Primary Designation Director
Industry Pharma
First Appointment 15 Jan 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arvigen Healthcare Private Limited U24100PN2019PTC181447
Director15 Jan 20192019Active

Board colleagues of Nanasaheb Vishwanath Nagare

NameDINCompanyDesignation
Ganesh Vishvnath Nagare08332240Arvigen Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arvigen Healthcare Private Limited
Premium access

Shareholding and investment profile for Nanasaheb Vishwanath Nagare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanasaheb Vishwanath Nagare

Nanasaheb Vishwanath Nagare currently holds 1 directorship: Arvigen Healthcare Private Limited (Director, since 15 Jan 2019).

Nanasaheb Vishwanath Nagare was first appointed on 15 Jan 2019 as Director at Arvigen Healthcare Private Limited.

The current boards of Nanasaheb Vishwanath Nagare's companies include Ganesh Vishvnath Nagare (Arvigen Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available